Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-transretinoic acid and arsenic trioxide-Reference-Cited by-同舟云学术

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-transretinoic acid and arsenic trioxide

Published:2015-07-24 Issue:4 Volume:171 Page:471-477
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sanford David¹,Lo-Coco Francesco²,Sanz Miguel A.³⁴,Di Bona Eros⁵,Coutre Steven⁶,Altman Jessica K.⁷,Wetzler Meir⁸,Allen Steven L.⁹,Ravandi Farhad¹,Kantarjian Hagop¹,Cortes Jorge E.¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Biomedicine and Prevention; University Tor Vergata of Rome; Rome Italy

3. Hematology Department; Hospital Universitario La Fe; Valencia Spain

4. Department of Medicine; University of Valencia; Valencia Spain

5. Hematology Unit; San Bortolo Hospital; Vicenza Italy

6. Stanford Cancer Center; Stanford University School of Medicine; Stanford CA USA

7. Robert H. Lurie Comprehensive Cancer Center; Northwestern University School of Medicine; Chicago IL USA

8. Medicine; Roswell Park Cancer Institute; Buffalo NY USA

9. Department of Medicine; Hofstra North Shore-Long Island Jewish School of Medicine; Hempstead NY USA

Funder

CytRx

CTI

MD Anderson Cancer Center Support Grant

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13607/fullpdf

Reference17 articles.

1. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein;Adamson;Cancer Research,1993

2. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia;Aribi;Cancer,2007

3. All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG);Asou;Cancer Chemotherapy and Pharmacology,1997

4. All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia;Cortes;Cancer,1994

5. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia;Estey;Blood,2006

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Realgar-indigo naturalis formula for the treatment of patients with relapsed and arsenic trioxide-resistant acute promyelocytic leukemia: A case series;Journal of Integrative Medicine;2024-08

2. Acute Promyelocytic Leukemia;Pediatric Oncology;2024

3. Drug repurposing for neurodegenerative diseases;Progress in Molecular Biology and Translational Science;2024

4. Targeting DHODH reveals therapeutic opportunities in ATRA-resistant acute promyelocytic leukemia;Biomedicine & Pharmacotherapy;2023-10

5. AI-Assisted Screening of Oral Potentially Malignant Disorders Using Smartphone-Based Photographic Images;Cancers;2023-08-16